Alpha 2.0
Login Register
» Authors » H M Vesterinen

H M Vesterinen

Explore the profile of H M Vesterinen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 310
Followers 0
Related Specialties
Neurology
Oncology
Veterinary Medicine
Top 10 Co-Authors
M R MacLeod
K J Egan
E S Sena
T C Hirst
A Antonic
D W Howells
G L Currie
L Churolov
I R Whittle
R Grant
Published In
Evid Based Preclin Med
J Neurosci Methods
Br J Cancer
Rev Sci Tech
Affiliations
Soon will be listed here.
Recent Articles
1.
Building capacity for World Trade Organization dispute settlement: piloting polarity mapping for trade relations
Vesterinen H, Perez A, Errecaborde K
Rev Sci Tech . 2020 Jul; 39(1):155-171. PMID: 32729571
Trade disputes have been on the rise in recent decades. Resolving these disputes can be challenging, even when relying on the World Trade Organization (WTO) formal dispute settlement system. Polarity...
2.
From a mouse: systematic analysis reveals limitations of experiments testing interventions in Alzheimer's disease mouse models
Egan K, Vesterinen H, Beglopoulos V, Sena E, MacLeod M
Evid Based Preclin Med . 2017 Dec; 3(1):e00015. PMID: 29214041
The increasing prevalence of Alzheimer's disease (AD) poses a considerable socio-economic challenge. Decades of experimental research have not led to the development of effective disease modifying interventions. A deeper understanding...
3.
Corrigendum to 'Meta-analysis of data from animal studies: A practical guide': [Journal of Neuroscience Methods 221 (2014) 92-102]
Vesterinen H, Sena E, Egan K, Hirst T, Churolov L, Currie G, et al.
J Neurosci Methods . 2017 Aug; 259:156. PMID: 28760532
No abstract available.
4.
A systematic review and meta-analysis of gene therapy in animal models of cerebral glioma: why did promise not translate to human therapy?
Hirst T, Vesterinen H, Conlin S, Egan K, Antonic A, Lawson McLean A, et al.
Evid Based Preclin Med . 2016 Sep; 1(1):e00006. PMID: 27668084
Background: The development of therapeutics is often characterized by promising animal research that fails to translate into clinical efficacy; this holds for the development of gene therapy in glioma. We...
5.
The development of an online database for interventions tested in transgenic mouse models of Alzheimer's disease
Egan K, Vesterinen H, McCann S, Sena E, MacLeod M
Evid Based Preclin Med . 2016 Aug; 2(1):e00010. PMID: 27570629
Despite many efforts by the research community, Alzheimer's disease (AD) is still an incurable neurodegenerative condition that affects an estimated 44 million individuals worldwide and this figure is expected to...
6.
Meta-analysis of data from animal studies: a practical guide
Vesterinen H, Sena E, Egan K, Hirst T, Churolov L, Currie G, et al.
J Neurosci Methods . 2013 Oct; 221:92-102. PMID: 24099992
Meta-analyses of data from human studies are invaluable resources in the life sciences and the methods to conduct these are well documented. Similarly there are a number of benefits in...
7.
Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted?
Hirst T, Vesterinen H, Sena E, Egan K, MacLeod M, Whittle I
Br J Cancer . 2013 Jan; 108(1):64-71. PMID: 23321511
Background: Malignant glioma is an aggressive tumour commonly associated with a dismal outcome despite optimal surgical and radio-chemotherapy. Since 2005 temozolomide has been established as first-line chemotherapy. We investigate the...